CoChat

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index; none of the 26 sources its claims cite is checked for support yet.

Preparation and Evaluation of Chitosan/PVA Based Hydrogel Films Loaded with Honey for Wound Healing Application

Open access

Abstract

In the present study, chitosan/polyvinyl alcohol (PVA)-based honey hydrogel films were developed for potential wound healing application. The hydrogel films were developed by a solvent-casting method and were evaluated in terms of thickness, weight variation, folding endurance, moisture content and moisture uptake. The water vapor transmission rate was found to range between 1650.50 ± 35.86 and 2698.65 ± 76.29 g/m2/day. The tensile strength and elongation at break were found to range between 4.74 ± 0.83 and 38.36 ± 5.39 N, and 30.58 ± 3.64 and 33.51 ± 2.47 mm, respectively, indicating significant mechanical properties of the films. SEM images indicated smooth surface morphology of the films. FTIR, DSC and in silico analysis were performed, which highlighted the docking energies of the protein–ligand complex and binding interactions such as hydrogen bonding, Pi–Pi bonding, and Pi–H bonding between the selected compounds and target proteins; hence, we concluded, with the three best molecules (lumichrome, galagin and chitosan), that there was wound healing potential. In vitro studies pointed toward a sustained release of honey from the films. The antimicrobial performance of the films was investigated against Staphylococcus aureus. Overall, the results signaled the potential application of chitosan/PVA based hydrogel films as wound dressings. Furthermore, in vivo experiments may be required to evaluate the clinical efficacy of honey-loaded chitosan/PVA hydrogel films in wound healing.

Overview

CoChat Summary

TL;DR

Chitosan/PVA hydrogel films loaded with honey were prepared by solvent casting and characterized for potential wound-healing application. They showed chitosan-dependent mechanical, moisture, barrier, release, antimicrobial, and in silico docking properties, but in vivo efficacy was not tested.

Key findings

  • Films F1–F5 had thickness 0.041 ± 0.006 to 0.055 ± 0.004 mm, weight variation 0.425 ± 0.02 to 0.480 ± 0.04 g, folding endurance increasing from 350 ± 15 to 445 ± 7, moisture content 18.10 ± 1.05 to 24.22 ± 2.37%, and moisture uptake 11.35 ± 0.07 to 14.96 ± 0.06%.
  • WVTR decreased significantly with increasing chitosan from 2698.65 ± 76.29 to 1650.50 ± 35.86 g/m²/day (p ≤ 0.05); tensile strength ranged from 4.74 ± 0.83 to 38.36 ± 5.39 N and elongation at break from 30.58 ± 3.64 to 33.51 ± 2.47 mm.
  • In vitro honey release was sustained; Korsmeyer–Peppas was the best-fit model except for F1, with F1–F3 n = 0.359–0.428 indicating Fickian diffusion and F4/F5 n = 0.688 and 0.604 indicating anomalous release. Against Staphylococcus aureus, F4 produced a zone of inhibition of 5.01 ± 0.32 mm.
  • Molecular docking of 14 compounds identified lumichrome, galagin, and chitosan as best molecules; chitosan had docking scores of −11.8369 (HNE), −11.6352 (MMP-3), and −12.8897 kcal/mol (MMP-9), while lumichrome scored −6.0911, −7.3801, and −6.9001 kcal/mol, and galagin scored −6.0133, −7.3211, and −6.8556 kcal/mol.

Methods

  • Hydrogel films were prepared by solvent casting: chitosan dissolved in 3% v/v acetic acid, PVA 5% w/v in distilled water, combined with honey in variable proportions, blended at 1000 rpm for 10 min, and air-dried for 2 days to form batches F1–F5.
  • Films were evaluated for thickness, weight variation, folding endurance, moisture content/uptake, swelling, WVTR (ASTM D6701-21), mechanical properties, FTIR, SEM, DSC, in vitro release at pH 7.4/37 °C with UV detection at 500 nm and kinetic modeling, antimicrobial disc diffusion against Staphylococcus aureus, and ICH stability at 40 ± 2 °C/75 ± 5% RH for 3 months.
  • In silico docking used 14 compounds (12 honey extracts plus PVA and chitosan) in MOE against HNE (PDB 1H1B), MMP-3 (PDB 1QIB), and MMP-9 (PDB 4H1Q); experiments were performed in triplicate with one-way ANOVA and p ≤ 0.05.

Limitations

  • The paper states that in vivo experiments may be required and could be significant to evaluate clinical efficacy; no in vivo data are reported.
  • Evident from the text: antimicrobial testing was performed only against Staphylococcus aureus, with no testing against other wound pathogens, and no cytotoxicity, biocompatibility, or animal/human wound-healing data are presented.
  • Evident from the text: docking results are computational only, and stability testing was limited to 3 months under one accelerated condition.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/gels8020111

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Pictorial Representation of various hydrogel films F1–F5.
Figure 1 Pictorial Representation of various hydrogel films F1–F5.CC BY · PubMed Central
Figure 2 Swelling ratio hydrogel film batches (n = 3).
Figure 2 Swelling ratio hydrogel film batches (n = 3).CC BY · PubMed Central
Figure 3 FTIR spectra of (A) PVA, (B) chitosan, (C) film with honey (formulation containing PVA/chitosan/honey), (D) honey, (E) film without honey (formulation containing PVA/chitosan).
Figure 3 FTIR spectra of (A) PVA, (B) chitosan, (C) film with honey (formulation containing PVA/chitosan/honey), (D) honey, (E) film without honey (formulation containing PVA/chitosan).CC BY · PubMed Central
Figure 4 SEM images of hydrogel films: (A) F1 batch; (B) F5 batch.
Figure 4 SEM images of hydrogel films: (A) F1 batch; (B) F5 batch.CC BY · PubMed Central
Figure 5 DSC thermograms of Chitosan, PVA, Honey, and Hydrogel film F5 batches.
Figure 5 DSC thermograms of Chitosan, PVA, Honey, and Hydrogel film F5 batches.CC BY · PubMed Central
Figure 6 In vitro drug release profiles from different batches of hydrogel films.
Figure 6 In vitro drug release profiles from different batches of hydrogel films.CC BY · PubMed Central
Figure 7 Microbial plates representing zone of inhibition for control, honey and hydrogel film.
Figure 7 Microbial plates representing zone of inhibition for control, honey and hydrogel film.CC BY · PubMed Central
Figure 8 Dataset of 14 compounds used for molecular docking analysis.
Figure 8 Dataset of 14 compounds used for molecular docking analysis.CC BY · PubMed Central
Figure 9 Three-dimensional representation of selected target proteins used for molecular docking: (A) human neutrophil elastase (HNE) (PDB ID: 1H1B); (B) matrix metalloproteinase-3 (MMP-3) (PDB ID: 1QIB); (C) matrix metallopeptidase 9 (MMP-9) (PDB ID: 4H1Q).
Figure 9 Three-dimensional representation of selected target proteins used for molecular docking: (A) human neutrophil elastase (HNE) (PDB ID: 1H1B); (B) matrix metalloproteinase-3 (MMP-3) (PDB ID: 1QIB); (C) matrix metallopeptidase 9 (MMP-9) (PDB ID: 4H1Q).CC BY · PubMed Central
Figure 10 Schematic representation of Compound 11 “lumichrome” bonded in the active site of selected three proteins (PDB ID: 1H1B (A), 1QIB (B) and 4H1Q (C)). The active binding site shows hydrogen-bonding capacity as donor atoms (purple), and acceptor atoms (green), a two-dimensional plot showing hydrogen bonding interactions and other important hydrophobic interacting residues of the target proteins.
Figure 10 Schematic representation of Compound 11 “lumichrome” bonded in the active site of selected three proteins (PDB ID: 1H1B (A), 1QIB (B) and 4H1Q (C)). The active binding site shows hydrogen-bonding capacity as donor atoms (purple), and acceptor atoms (green), a two-dimensional plot showing hydrogen bonding interactions and other important hydrophobic interacting residues of the target proteins.CC BY · PubMed Central
Figure 11 Schematic representation of Compound 12 “galagin” bonded in the active site of selected three proteins (PDB ID: 1H1B (A), 1QIB (B) and 4H1Q (C)). The active binding site shows hydrogen-bonding capacity as donor atoms (purple), and acceptor atoms (green), a two-dimensional plot showing hydrogen bonding interactions and other important hydrophobic interacting residues of the target proteins.
Figure 11 Schematic representation of Compound 12 “galagin” bonded in the active site of selected three proteins (PDB ID: 1H1B (A), 1QIB (B) and 4H1Q (C)). The active binding site shows hydrogen-bonding capacity as donor atoms (purple), and acceptor atoms (green), a two-dimensional plot showing hydrogen bonding interactions and other important hydrophobic interacting residues of the target proteins.CC BY · PubMed Central
Figure 12 Schematic representation of Compound 13 “chitosan” bonded in the active site of selected three proteins (PDB ID: 1H1B (A), 1QIB (B) and 4H1Q (C)). The active binding site shows hydrogen bonding capacity as donor atoms (purple), and acceptor atoms (green), a two-dimensional plot showing hydrogen bonding interactions and other important hydrophobic interacting residues of the target proteins.
Figure 12 Schematic representation of Compound 13 “chitosan” bonded in the active site of selected three proteins (PDB ID: 1H1B (A), 1QIB (B) and 4H1Q (C)). The active binding site shows hydrogen bonding capacity as donor atoms (purple), and acceptor atoms (green), a two-dimensional plot showing hydrogen bonding interactions and other important hydrophobic interacting residues of the target proteins.CC BY · PubMed Central

Verification

Claims the paper makes

0 Valid · 0 Not valid · 20 Not checked · 62 Own results and interpretations

44 more claims

Create a free account to see all 82 claims and to verify the 26 references still open.

See all claims — free account
  • It may state two separate claims as one. 20
  • Probably not a substantial claim. 16

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

5 of 6 · the rest aren’t loaded

1 more finding

Create a free account to see every finding of this check.

See all findings — free account

Citations

Cites

Show all 47 references

Cited by

Items 101–200 of 244

Metadata

Authors
Chopra, H., Bibi, S., Kumar, S., Khan, M. S., Kumar, P., & Singh, I.
Affiliations
  • Chitkara University (IN)
  • Yunnan University (CN)
  • College of Pharmacy, Amar Shaheed Baba Ajit Singh Jujhar Singh Memorial College, Ropar 140111, Punjab, India
  • COMSATS University Islamabad (PK)
  • University of the Witwatersrand (ZA)
Corresponding author
  • Kumar, Pradeep
  • Singh, Inderbir
Venue
Gels
Publisher
MDPI AG
Published
2022-02-11
Volume
8
Issue
2
Pages
111
ISSN
2310-2861 (ISSN-L)
OpenAlex
W4213169804
Cited by
245
References
47
Citations by year
2026: 60 · 2025: 63 · 2024: 65 · 2023: 43 · 2022: 14
FWCI
36.20
Type
journal article
Language
en
Open access
Locations
  • Gels (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Surgery › Wound Healing and Treatments
  • Physical Sciences › Materials Science › Biomaterials › Hydrogels: synthesis, properties, applications
  • Physical Sciences › Materials Science › Biomaterials › Nanocomposite Films for Food Packaging
Keywords
chitosan, polyvinyl alcohol, hydrogel films, honey, wound healing, wound dressings, water vapor transmission rate, mechanical properties, protein-ligand docking, lumichrome, sustained drug release, antimicrobial activity, Staphylococcus aureus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-18, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-18 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.